DMDRMR promotes angiogenesis via antagonizing DAB2IP in clear cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC) patients are highly angiogenic and treated by targeted therapies against VEGFA/VEGFR signaling pathway. However, tumors with such targeted therapies remain a significant clinic challenge. Understanding the underlying mechanism against angiogenesis is highly de...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yumeng, Liu, Xiaojun, Wang, Yang, Pan, Yongbo, Han, Xiaoqi, Peng, Bo, Zhang, Xu, Niu, Shaoxi, Wang, He, Ye, Qinong, Gu, Yinmin, Gao, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106801/
https://www.ncbi.nlm.nih.gov/pubmed/35562342
http://dx.doi.org/10.1038/s41419-022-04898-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106801/
https://www.ncbi.nlm.nih.gov/pubmed/35562342
http://dx.doi.org/10.1038/s41419-022-04898-3

Ejemplares similares